Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER.

Beverly M K Biller Charlotte HöybyeJean-Marc FerranNicky KelepourisNavid NedjatianAnne Helene OlsenMatthias M WeberMurray B Gordon

Published in: Journal of the Endocrine Society (2023)

Clinical outcomes of GHRT in AGHD were similar in middle-aged and older patients, with no significantly increased risk of GHRT-related adverse reactions in older patients.

Keyphrases

replacement therapy
smoking cessation
community dwelling
electronic health record
physical activity
middle aged
big data
growth hormone